Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.940
+0.090 (1.86%)
Oct 7, 2026, 10:37 AM EDT - Market open
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $115.88 million as of October 7, 2026. Its market cap has increased by 6.59% in one year.
Market Cap
115.88M
Enterprise Value
72.70M
1-Year Change
6.59%
Ranking
Category
Stock Price
$4.94
ChartMarket Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $115.88M, an increase of 878.96%. That is a compound annual growth rate of 82.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 115.88M | -4.52% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Seer, Inc. | 122.33M |
| Cibus | 122.29M |
| TuHURA Biosciences | 122.06M |
| enGene Therapeutics | 121.97M |
| Inovio Pharmaceuticals | 117.87M |
| Unicycive Therapeutics | 117.55M |
| LENZ Therapeutics | 116.26M |
| Genelux | 115.61M |